Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 37.55 (-2.17), BA: 124.25 (+2.17), BCPC: 65.24 (+1.89), MMS: 51.00 (+0.67)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.77 (-0.27), MJN: 95.45 (-0.75), CBM: 23.35 (+0.01), SIAL: 136.10 (+0.19), USNA: 99.85 (+0.80), SYUT: 5.06 (+0.06), MTEX: 29.26 (-0.14), BCPC: 65.24 (+1.89)
Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST
HOG: 62.70 (-3.65), LAZ: 47.09 (-0.94), AIV: 35.66 (-0.28), CNP: 21.71 (+0.17), AIT: 43.34 (-0.17), UPS: 109.83 (-0.92), SLB: 80.19 (+0.29), PRI: 51.29 (-0.16), VLO: 47.03 (+0.92), MAT: 30.52 (-0.06), AJG: 46.28 (-0.29), MMLP: 27.96 (+1.41), HME: 64.39 (+0.43), MWE: 61.36 (+0.14), RES: 12.50 (+0.39), INGR: 81.22 (-0.85), PFE: 30.67 (-0.19), ALL: 67.21 (-0.16), CLB: 114.83 (+1.87), RAS: 7.08 (+0.02), MCO: 92.38 (-1.41), FLIR: 31.51 (-0.24), SMP: 35.36 (-0.51), CPA: 88.12 (-5.79), ARCP: 7.70 (-0.53), HEI: 56.99 (+3.17), EWBC: 37.09 (-0.13), MKTX: 68.60 (+0.10), SNI: 76.25 (+0.38), BCPC: 65.24 (+1.89), FCF: 8.60 (+0.09), GMT: 53.73 (+0.22), ALE: 52.09 (+0.13), TAL: 39.39 (-0.49), EMCF: 25.25 (+0.75), WDR: 43.85 (-0.30), TLLP: 51.32 (+0.03), EPR: 55.66 (+0.75), EME: 41.50 (-0.07), PCBK: 13.55 (+0.01), X: 27.90 (+0.19), CMS: 33.26 (-0.05), LGCY: 11.68 (+1.13), CUBE: 21.47 (+0.12), AMGN: 159.44 (-0.16), EFX: 79.60 (-0.26), ATK: 101.76 (-0.09), FINL: 28.14 (-0.29), LEA: 91.50 (+0.60), TESS: 27.00 (-0.06), LB: 81.25 (-1.91), HPY: 51.28 (-0.71), DNB: 114.54 (-0.39), BIP: 39.59 (-0.32), TOO: 22.37 (+0.76), FIBK: 26.31 (-0.32), CNA: 37.11 (+0.06), MOFG: 27.72 (-0.34)
Balchem Has Returned 14.2% Since SmarTrend Recommendation (BCPC)
Comtex SmarTrend(R) - Thu Dec 04, 9:49AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 months, Balchem has returned 14.19% as of today's recent price of $65.11.
BCPC: 65.24 (+1.89)
Balchem Announces Investment in Agglomeration Technology
GlobeNewswire - Tue Nov 25, 3:39PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its SensoryEffects business segment will make a multi-million dollar investment in agglomeration technology and production equipment to complement its market leading capabilities in drying and blending of emulsified powders for various markets.
BCPC: 65.24 (+1.89)
Post Earnings Update: Balchem Has Sunk 3.2% Lower in Past 2 Weeks (BCPC)
Comtex SmarTrend(R) - Mon Nov 24, 8:42AM CST
14 days ago, on November 10th, 2014, Balchem (NASDAQ:BCPC) reported its earnings. Analysts, on average, expected earnings of $0.51 per share on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Since the company's report, shares of Balchem have fallen from $65.73 to $63.61, representing a loss of 3.2% in the past 14 days.
BCPC: 65.24 (+1.89)
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Balchem Is Down 1.4% (BCPC)
Comtex SmarTrend(R) - Mon Nov 17, 2:55PM CST
A week ago on November 10th, 2014 Balchem (NASDAQ:BCPC) reported earnings and analysts, on average, expected earnings of $0.51 on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Shares of Balchem have slipped from $65.73 to $64.84, representing a loss of 1.4%, since the company reported earnings 7 days ago.
BCPC: 65.24 (+1.89)
Uptrend Call Working As Balchem Stock Rises 14.0% (BCPC)
Comtex SmarTrend(R) - Mon Nov 17, 10:49AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 1 month, Balchem has returned 13.97% as of today's recent price of $64.99.
BCPC: 65.24 (+1.89)
Dividend Challengers (And Near-Challengers): 44 Increase Expected By January 31
David Fish - at Seeking Alpha - Mon Nov 17, 3:57AM CST
WDFC: 78.79 (+2.48), EWBC: 37.09 (-0.13), TTC: 60.82 (-0.07), OCR: 70.26 (-0.81), GE: 24.49 (-0.10), MAIN: 28.08 (-1.51), HI: 31.69 (+0.41), DEI: 27.52 (+0.02), BLX: 30.08 (-0.49), THG: 68.49 (-0.04), RL: 176.60 (-3.43), BCPC: 65.24 (+1.89), AET: 85.64 (-1.03), VTR: 71.99 (-0.73), WDR: 43.85 (-0.30), TLLP: 51.32 (+0.03), PCBK: 13.55 (+0.01), EME: 41.50 (-0.07), EPR: 55.66 (+0.75), CHS: 15.73 (-0.07), LGCY: 11.68 (+1.13), BMR: 20.94 (-0.21), EMN: 71.57 (-0.48), INGR: 81.22 (-0.85), PRA: 46.40 (-0.57), CUBE: 21.47 (+0.12), DIS: 90.17 (-0.73), COR: 37.59 (-0.17), BMY: 57.69 (-0.86), MORN: 64.29 (+0.33), EXL: 12.87 (-0.03), RAS: 7.08 (+0.02), CLB: 114.83 (+1.87), RCII: 32.64 (+0.08), TESS: 27.00 (-0.06), BGS: 29.47 (+0.43), TOO: 22.37 (+0.76), FIBK: 26.31 (-0.32), MAA: 72.45 (+0.14), HEI: 56.99 (+3.17), JCI: 44.90 (-0.74)
Balchem's (BCPC) CEO Dino Rossi Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 5:08PM CST
BCPC: 65.24 (+1.89)
Balchem Up 13.2% Since SmarTrend Uptrend Call (BCPC)
Comtex SmarTrend(R) - Mon Nov 10, 10:00AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 4 weeks, Balchem has returned 13.21% as of today's recent price of $64.55.
BCPC: 65.24 (+1.89)
Today's Strong And Under The Radar Stock Is Balchem (BCPC)
at The Street - Mon Nov 10, 8:47AM CST
Trade-Ideas LLC identified Balchem (BCPC) as a strong and under the radar candidate
BCPC: 65.24 (+1.89)
Blachem posts 3Q profit
Automated Insights - Mon Nov 10, 8:39AM CST
NEW HAMPTON, N.Y. (AP) _ Balchem Corp. (BCPC) on Monday reported profit of $15.2 million in its third quarter.
BCPC: 65.24 (+1.89)
Balchem beats by $0.14, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:33AM CST
BCPC: 65.24 (+1.89)
Balchem Corporation Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 8:30AM CST
Balchem Corporation (Nasdaq:BCPC) reported as follows (unaudited) for the period ended September 30, 2014.
BCPC: 65.24 (+1.89)
Shares of BCPC Up 12.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Oct 31, 10:05AM CDT
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 weeks, Balchem has returned 12.61% as of today's recent price of $64.21.
BCPC: 65.24 (+1.89)
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on November 10, 2014
GlobeNewswire - Wed Oct 29, 3:15PM CDT
Balchem Corporation (Nasdaq:BCPC) today announced that a conference call will be held on Monday, November 10, 2014, at 11:00 AM Eastern Time (ET) to review third quarter 2014 results. Dino A. Rossi, Chairman, President and CEO, and Bill Backus, Chief Financial Officer, will host the call.
BCPC: 65.24 (+1.89)
Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT
RKT: 58.92 (+0.82), TTC: 60.82 (-0.07), HST: 23.33 (+0.08), OCR: 70.26 (-0.81), HI: 31.69 (+0.41), MAIN: 28.08 (-1.51), MHLD: 12.56 (-0.04), PRU: 84.74 (-0.88), DEI: 27.52 (+0.02), PSA: 178.85 (-1.22), THG: 68.49 (-0.04), KKR: 21.82 (-0.27), RL: 176.60 (-3.43), VTR: 71.99 (-0.73), AEP: 57.83 (-0.25), EVR: 48.64 (+0.36), TECH: 90.21 (-1.34), ROK: 104.83 (+1.45), INGR: 81.22 (-0.85), WTI: 5.83 (+0.34), COR: 37.59 (-0.17), EXL: 12.87 (-0.03), UG: 19.70 (+0.50), BGS: 29.47 (+0.43), ESV: 27.21 (+0.80), APTS: 8.70 (unch), EL: 72.99 (+0.76), HEI: 56.99 (+3.17), GE: 24.49 (-0.10), BOKF: 58.25 (+0.34), SNA: 132.53 (-0.04), BCPC: 65.24 (+1.89), SBUX: 79.13 (-1.76), V: 253.41 (-3.29), KIM: 24.93 (-0.13), BBSI: 25.77 (-0.75), SIX: 41.15 (-0.62), EMCI: 32.49 (+0.08), CHS: 15.73 (-0.07), NEU: 376.89 (+1.25), BMR: 20.94 (-0.21), EMN: 71.57 (-0.48), PRA: 46.40 (-0.57), CBL: 18.67 (-0.19), CUBE: 21.47 (+0.12), DIS: 90.17 (-0.73), BMY: 57.69 (-0.86), ABC: 89.43 (-1.26), RCII: 32.64 (+0.08), WCN: 43.35 (-0.05), HCI: 41.75 (+0.47), MAC: 80.22 (+0.23), AMTD: 33.97 (-0.50), HUB.B: 101.44 (-0.08), JCI: 44.90 (-0.74)
Dairy: The Future Of Protein - Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts
M2 - Mon Oct 06, 9:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w9wq33/dairy_the) has announced the addition of the "Dairy: The Future Of Protein - Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts" report to their offering. The long-term thesis supporting the market for protein is hard to ignore: more people equals more mouths to feed, while the shift in diets, notably among emerging markets, will drive increased demand for protein of all types. This implies a substantial revenue opportunity for those facilitating the procurement, trading, storage, and transportation of protein products. This report focuses on Dairy protein only, whose production is estimated at USD354.4 billion in 2014, and is forecast to grow more than 10% annually over the next five years. Topics covered in the report include global protein production by class and type, dairy production by type and region, dairy retail sales, exports, imports, foreign markets, the feed outlook, alfalfa production, yogurt demand and the Chinese infant milk formula market, among others. The report contains detailed analysis of the major dairy market players in terms of their product offerings, markets served, strategies, competitors and financial performance. In addition to profiles of 34 public companies involved in the dairy industry, the report also contains 78 tables and 125 figures. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Protein Overview 4. Protein Market Overview 5. Dairy Protein Market Companies Mentioned: - AGCO Corporation - Archer Daniels Midland Company - Balchem Corporation - Beingmate Baby & Child Food - Biostime International - Bunge Limited - China Mengniu Dairy Company Limited - China Modern Dairy Holdings - Chr. Hansen Holding - Dairy Crest Group - Danone - Dean Foods Company - Deere & Company - Dupont E I De Nemours & Co - Emmi - Farmland Partners Inc. - Fonterra Co-operative Group Limited - General Mills - Glanbia plc - Gloria SA - Kraft Foods Group - Mead Johnson Nutrition Company - Megmilk Snow Brand - Meiji Holdings - Monsanto - Morinaga Milk Industry - Nestle SA - Phibro Animal Health - Ridley Inc.. - S&W Seed Company - Syngenta - Synlait Milk Limited - Synutra International - Yakult Honsha - Yili Group For more information visit http://www.researchandmarkets.com/research/w9wq33/dairy_the
KRFTV: 44.10 (-0.53), SANW: 3.68 (+0.16), PAHC: 29.10 (-0.08), FPI: 11.02 (+0.01), AGCO: 43.93 (+0.08), SYUT: 5.06 (+0.06), BCPC: 65.24 (+1.89), BG: 88.86 (-0.83), MJN: 95.45 (-0.75), ADM: 49.32 (-0.51), DE: 87.80 (+0.33), DF: 17.69 (-0.07), GIS: 51.13 (-0.34)